Overview
- Updated totals put the film at $11.7 million in North America, $2.1 million internationally, and $13.8 million worldwide, per Box Office Mojo figures cited on Jan. 18.
- Industry estimates suggest a break-even range around $180–$225 million, highlighting how little of its costs the movie has recovered so far.
- Critical reception is muted, with a 48–49% Rotten Tomatoes critics score and a 1.5-star review from The Indian Express.
- The sequel trails fellow January release Primate in both domestic and global earnings, according to box office trackers.
- Trade coverage notes it must look to overseas markets for improvement as fresh competition arrives from 28 Years Later: The Bone Temple, Mercy, and Shelter.